This is a Validated Antibody Database (VAD) review about mouse Folh1, based on 4 published articles (read how Labome selects the articles), using Folh1 antibody in all methods. It is aimed to help Labome visitors find the most suited Folh1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Folh1 synonym: GCP2; mopsm; glutamate carboxypeptidase 2; FGCP; GCPII; N-acetylated-alpha-linked acidic dipeptidase I; NAALADase I; folylpoly-gamma-glutamate carboxypeptidase; glutamate carboxypeptidase II; mGCP; membrane glutamate carboxypeptidase; prostate-specific membrane antigen homolog; pteroylpoly-gamma-glutamate carboxypeptidase
Abcam
| mouse monoclonal (YPSMA-1) |
| Abcam Folh1 antibody (Abcam, ab19071) was used in western blot on human samples at 1:1000 (fig 1). Sci Rep (2016) ncbi |
| mouse monoclonal (YPSMA-1) |
| In order to assess the effect on killing efficacy of the intracellular trafficking patterns of beta-particle emitters, Abcam Folh1 antibody (Abcam, ab19071) was used in western blot on human samples . Mol Cancer Ther (2016) ncbi |
| mouse monoclonal (YPSMA-1) |
| Abcam Folh1 antibody (Abcam, YPSMA-1) was used in immunohistochemistry - paraffin section on human samples at 1:400. Int J Mol Sci (2014) ncbi |
| mouse monoclonal (YPSMA-1) |
| Abcam Folh1 antibody (Abcam, YPSMA-1) was used in ELISA on human samples . J Transl Med (2013) ncbi |
Articles Reviewed
- Zhu C, Bandekar A, Sempkowski M, Banerjee S, Pomper M, Bruchertseifer F, et al. Nanoconjugation of PSMA-Targeting Ligands Enhances Perinuclear Localization and Improves Efficacy of Delivered Alpha-Particle Emitters against Tumor Endothelial Analogues. Mol Cancer Ther. 2016;15:106-113 pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments
